HESI Evolve Practice Exam 2025 Latest Update | Accurate Detailed Answers With Rationales | Guaranteed Pass!!!

HESI Evolve Practice Exam 2025 Latest
Update | Accurate Detailed Answers With
Rationales | Guaranteed Pass!!!

anaqantacidaq(Maalox)aqisaqprescribedaqforaqaaqclientaqwithaqpepticaqulceraqdisease.aqtheaqnurseaqk
nowsaqthataqtheaqpurposeaqofaqthisaqmedicatioaqis:
A. decreaseaqproductionaqofaqgastricaqsecretions
B. produceaqanaqadherentaqbarrieraqoveraqtheaqulcer
C. maintainaqaaqgastricaqpHaqofaq3.5aqoraqhigher
D. decreaseaqgastricaqmotoraqactivityaq-aqC.aqmaintainaqaaqgastricaqpHaqofaq3.5aqoraqhigher

rationale:aqobjectiveaqofaqantacidsaqisaqtoaqneutralizeaqgastricaqacidsaqandaqkeepaqaaqpHaqofaq3.5aqo
raqabove,aqwhichaqisaqnecessaryaqforaqpepsinogenaqactivity

Inaqevaluationaqtheaqeffectsaqofaqlactuloseaq(Cephulac),aqwhichaqoutcomeaqwouldaqindicateaqthataq
theaqdrugaqisaqperformingaqasaqintended?
A. increaseaqinaqurineaqoutput
B. 2aqoraq3aqsoftaqstoolsaqperaqday.
C. watery,aqdiarrheaaqstools
D. increasedaqserumaqbilirubinaq-aqB.aq2aqoraq3aqsoftaqstoolsaqperaqday.

Theaqhealthcareaqprovideraqprescribesaqdigitalisaq(Digoxin)aqforaqaaqclientaqdiagnosedaqwithaqCH
F.aqwhichaqinterventionaqshouldaqtheaqnurseaqimplementaqprioraqtoaqadministeringaqDigoxin?
A. observeaqrespiratoryaqrateaqandaqdepth
B. assessaqserumaqpotassiumaqlevel
C. obtainaqtheaqclient'saqBP
D. Monitoraqtheaqserumaqglucoseaqlevelaq-aqB.aqassessaqserumaqpotassiumaqlevel

Followingaqtheaqadministrationaqofaqsublingualaqnitroglycerinaqtoaqaaqclientaqexperiencingaqanaqa
cuteaqanginalaqattack,aqwhichaqassessmentaqfindingaqindicatesaqtoaqtheaqnurseaqthataqtheaqdesir
edaqeffectaqhasaqbeenaqachieved?
A. clientaqstatesaqchestaqpainaqisaqrelieved
B. client'saqpulseaqdecreasesaqfromaq120aqtoaq90
C. client'saqsystolicaqBPaqdecreasesaqfromaq180aqtoaq90.
D. clientsaqOxygenaqlevelaqincreasesaqformaq92%aqtoaq96%aq-
aqA.aqclientaqstatesaqchestaqpainaqisaqrelieved




AaqclientaqwithaqCHFaqisaqbeingaqdischargesaqwithaqaaqnewaqprescriptionaqforaqACEaqinhibitoraqCap
toprilaq(Capoten).aqTheaqnurse'saqdischargeaqinstructionaqshouldaqincludeaqreportingaqwhichaqpr
oblemaqtoaqtheaqhealthaqcareaqprovider?
A. weightaqloss
B. Dizziness
C. Muscleaqcramps

,D. Dryaqmucousaqmembreanesaq-aqB.aqDizziness

Aaqclientaqisaqbeingaqtreatedaqforaqhyperthyroidismaqwithaqpropylthiouracilaq(PTU).aqTheaqnu
rseaqknowsaqthataqtheaqactionaqofaqthisaqdrugaqisaqto:
A. decreaseaqtheaqamountaqofaqthyroid-stimulatingaqhormoneaqcirculatingaqinaqtheaqblood.
B. increaseaqtheaqamountaqofaqthyroid-stimulatingaqhormoneaqcirculatingaqinaqtheaqblood.
C. increaseaqtheaqamountaqofaqT4aqandaqdecreaseaqtheaqamountaqofaqT3aqproducedaqbyaqtheaqthyro
id.
D. inhibitaqsynthesisaqofaqT3aqandaqT4aqbyaqtheaqthyroidaqglanfaq-
aqD.aqinhibitsaqsynthesisaqofaqT3aqand aqT4aqbyaqthe aqthyroidaqgland.




AaqclientaqwithaqParkinson'saqdiseaseaqisaqtakingaqcarbidopa-
levadopaaq(Sinemet).aqwhichaqobservationaqbyaqtheaqnurseaqwouldaqindicateaqthataqtheaqdesired
aqoutcome aqofaqthe aqmedicationaqisaqbeingaqachieved?

A. decreasedaqBP
B. lesseningaqofaqtremors
C. increasedaqsalivation
D. increasedaqattentionaqspanaq-aqB.aqlesseningaqofaqtremors

rationale:aqsinemetaqcarbidopaaqincreasesaqtheaqamountaqofaqlevodopaaqtoaqtheaqCNSaq(dopami
neaqtoaqtheaqbrain).aqincreasedaqamountsaqofaqdopamineaqimproveaqtheaqsymptomsaqofaqParkin
sons,aqsuchaqasaqinvoluntaryaqmovements,aqrestingaqtremors,aqshufflingaqair,aqetc.aqdecaqdrooli
ngaqwouldaqbeaqaaqdesiredaqeffectaqofaqlevodopa/carbidopa

Followingaqheparinaqtreatmentaqforaqaaqpulmonaryaqembolism,aqaaqclientaqisaqbeingaqdischargeda
qwithaqaaqprescriptionaqforaqwarfarinaq(coumadin).aqInaqconductingaqdischarge aqteaching,aqtheaq

nurseaqadvisesaqtheaqclientaqtoaqhaveaqwhichaqdiagnosticaqtestaqmonitoredaqregularlyaqafteraqdis
charge?
A. perfusionaqscan
B. ProthrombinaqTimeaq(PT/INR)
C. activatedaqpartialaqthromboplastinaq(APPT)
D. serumaqcoumadinaqlevelaq(SCL).aq-aqB.aqprothrombinaqtimeaq(PT/INR)

rationale:aqwhenaqusedaqforaqaaqclientaqwithaqaaqpulmonaryaqembolus,aqtheaqtheraputicaqgoal
aqforaqwarfarinaqtherapyaqisaq1-2xaqgreateraqthan aqtheaqcontrol,aqOrraqanaqINRaqofaq2-3




AaqpostoperativeaqclientaqhasaqbeenaqreceivingaqaaqcontinuousaqIVaqinfusionaqofaqmeperidineaq(d
emerol)aq35mg/hraqforaqfouraqdays.aqtheaqclientaqhasaqaaqPRNaqprescriptionaqforaqDemerolaq100aq
mgaqPOaqq3h.aqTheaqnurseaqnotesaqthataqtheaqclientaqhasaqbecomeaqincreasinglyaqrestless,aqirrita
bleaqandaqconfused,aqstatingaqthataqthereaqareaqbugsaqallaqoveraqtheaqwalls.aqwhataqactionaqshould
aqthe aqnurseaqtakeaqfirst?

A. administeraqaaqPRNaqdoseaqofaqPOaqmeperidineaq(Demerol).
B. administeraqnaloxoneaq(Narcan)aqIVaqperaqPRNaqprotocol/
C. DecreaseaqtheaqIVaqinfusionaqrateaqofaqtheaqmeperidineaq(Demerol)aqperaqprotocol.
D. notifyaqtheaqhealthcareaqprovideraqofaqtheaqclient'saqconfusionaqandaqhallucinationsaq
-
aqC.aqDecreaseaqthe aqIVaqinfusionaqrateaqofaqtheaqmeperidineaq(Demerol)aqperaqprotocol

.

, Aaqclientaqisaqbeingaqtreatedaqforaqosteoporosisaqwithaqalendronateaq(fosamax),aqandaqtheaqnursea
qhasaqcompleted aqdischargeaqteaching aqregarding aqmedicationaqadministration.aqWhichaqmor

ningaqscheduleaqwouldaqindicateaqtoaqtheaqnurseaqthataqtheaqclientaqteachingaqhasaqbeenaqeffectiv
e?
A. takeaqmedication,aqgoaqforaqaaq30aqminuteaqmorningaqwalk,aqthenaqeataqbreakfast
B. takeaqmedication,aqrestaqinaqbedaqforaq30aqminutesaq,aqeataqbreakfast,aqgoaqforaqmorningaqwalk
C. takeaqmedicationaqwithaqbreakfast,aqthenaqtakeaqaaq30aqminuteaqmorningaqwalk.
D. goaqforaqaaq30aqminuteaqmorningaqwalk,aqeataqbreakfast,aqthenaqtakeaqmedicationaq-
aqA.aqtakeaqmedication,aqgoaqforaqaaq30aqminuteaqmorning aqwalk,aqthenaqeat aqbreakfast




Aaqclientaqisaqreceibingaqmetoprololaq(Lopressor).aqWhataqassessmentaqisaqmostaqimportantaqfora
qthe aqnurseaqtoaqobtain?

A. temp.
B. lungaqsounds
C. BP
D. urinaryaqoutputaq-aqC.aqBP

Aaqclientaqwithaqaaqdysrhythmiaaqisaqtoaqreceiveaqprocainamideaq(pronestyl)aqinaqdividedaq4aqdose
saqoveraqtheaqnextaq24aqhours.aqwhataqdosingaqscheduleaqisaqbestaqforaqtheaqnurseaqtoaqimplemen
t?
A. q6h
B. QID
C. ACaqandaqbedtime
D. PCaqandaqbedtimeaq-aqA.aqq6h

rationale:aqprocainamideaqisaqaaqclassaq1Aaqantidysrhythmic.aqitaqshouldaqbeaqtakenaqaroundaqth
eaqclock,aqsoaqthataqaaqstableaqbloodaqlevelaqofaqtheaqdrugaqcanaqbeaqmaintained,aqtherebyaqdecrea
singaqtheaqpossibilityaqofaqhypotensionaq(anaqadverseaqeffect)aqoccurringaqbecauseaqtooaqmuchaq
ofaqtheaqdrugaqcirculatingaqsystemicallyaqataqanyaqparticularaqtimeaqofaqtheaqday.aqpronestylaqmaya
qbeaqgiven aqwithaqfood aqifaqGIaqdistressaqisaqaaqproblem




Whichaqactionaqisaqmostaqimportantaqforaqtheaqnurseaqtoaqimplementaqprioraqtoaqtheaqadministratio
naqofaqtheaqantiarrhythmicaqdrugaqadenosineaq(adenocard)?
A. assessaqpupillaryaqresponseaqtoaqlight.
B. instructaqtheaqpatientaqthataqfacialaqflushingaqmayaqoccur
C. applyaqcontinuousaqcardiacaqmonitoring
D. requestaqthataqfamilyaqmembersaqleaveaqtheaqroomaq-
aqC.aqapplyaqcontinuousaqcardiacaqmonitoring




aaqclientaqhasaqcontinuousaqIVaqinfusionaqofaqdopamineaq(intropin)aqandaqanaqIVaqofaqnormalaqsali
neaqataq50aqml/hr.aqtheaqnurseaqnotesaqthataqtheaqclient;saqurinaryaqoutputaqhasaqbeenaq20aqml/hour
aqforaqthe aqlastaq2aqhours.aqwhichaqintervention aqshouldaqtheaqnurseaqinitiate?

A. stopaqtheaqinfusionaqofaqdopamine
B. changeaqtheaqnormalaqsalineaqtoaqkeepaqopenaqrate
C. replaceaqtheaqurinaryaqcatheter
D. notifyaqtheaqhealthcareaqprovideraqofaqtheaqurinaryaqoutput.aq-
aqD. aqnotifyaqthe aqhealthcareaqprovideraqofaqtheaqurinaryaqoutput.